We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
-7.31%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.64B
AUM Growth
-$239M
Cap. Flow
-$76.2M
Cap. Flow %
-4.65%
Top 10 Hldgs %
45.73%
Holding
139
New
1
Increased
10
Reduced
53
Closed
1

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.24M
2
CRNC icon
Cerence
CRNC
+$315K
3
ZIMV
ZimVie
ZIMV
+$250K
4
CALX icon
Calix
CALX
+$157K
5
KFY icon
Korn Ferry
KFY
+$119K

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$11.3M
2
SCHW
Charles Schwab
SCHW
+$9.32M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$9.31M
4
SNPS icon
Synopsys
SNPS
+$6.55M
5
MSFT icon
Microsoft
MSFT
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 41.59%
2 Communication Services 15%
3 Healthcare 14.31%
4 Consumer Discretionary 14.29%
5 Financials 11.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
76
Cardinal Health
CAH
$53.7B
$2.3M 0.14%
40,540
– –
VRNT
77
DELISTED
Verint Systems
VRNT
$2.29M 0.14%
44,220
– –
EXEL icon
78
Exelixis
EXEL
$13.9B
$2.25M 0.14%
99,343
– –
FFIV icon
79
F5
FFIV
$22B
$2.2M 0.13%
10,525
– –
TMO icon
80
Thermo Fisher Scientific
TMO
$214B
$2.19M 0.13%
3,703
-397
-10% -$228K
TSLA icon
81
Tesla
TSLA
$1.18T
$2.09M 0.13%
5,817
– –
PRFT
82
DELISTED
Perficient Inc
PRFT
$2.03M 0.12%
18,417
– –
CNXC icon
83
Concentrix
CNXC
$1.62B
$2M 0.12%
12,000
– –
MRK icon
84
Merck
MRK
$322B
$1.95M 0.12%
23,765
– –
AIT icon
85
Applied Industrial Technologies
AIT
$12.4B
$1.94M 0.12%
18,875
– –
AMBA icon
86
Ambarella
AMBA
$3.04B
$1.82M 0.11%
17,306
+240
+1% +$30.6K
UI icon
87
Ubiquiti
UI
$31.6B
$1.81M 0.11%
6,212
– –
CRL icon
88
Charles River Laboratories
CRL
$11.3B
$1.78M 0.11%
6,284
-600
-9% -$185K
VRTX icon
89
Vertex Pharmaceuticals
VRTX
$123B
$1.63M 0.1%
6,228
-178
-3% -$42.2K
JNJ icon
90
Johnson & Johnson
JNJ
$640B
$1.62M 0.1%
9,148
– –
NBIX icon
91
Neurocrine Biosciences
NBIX
$18.2B
$1.53M 0.09%
16,361
– –
LRCX icon
92
Lam Research
LRCX
$316B
$1.5M 0.09%
27,850
– –
PCTY icon
93
Paylocity
PCTY
$7.75B
$1.49M 0.09%
7,220
– –
MA icon
94
Mastercard
MA
$498B
$1.48M 0.09%
4,149
– –
FTNT icon
95
Fortinet
FTNT
$112B
$1.42M 0.09%
20,800
– –
HUM icon
96
Humana
HUM
$43.9B
$1.36M 0.08%
3,130
– –
CALX icon
97
Calix
CALX
$2.24B
$1.34M 0.08%
31,244
+3,095
+11% +$157K
MEDP icon
98
Medpace
MEDP
$16.3B
$1.32M 0.08%
8,097
– –
BIIB icon
99
Biogen
BIIB
$30.9B
$1.13M 0.07%
5,355
-650
-11% -$141K
CSGS
100
DELISTED
CSG Systems International
CSGS
$1.1M 0.07%
17,373
+1,000
+6% +$60.2K
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Oak Associates held 139 positions worth $1.64B, down 13% from $1.88B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Oak Associates withdrew a net $76.2M in Q1 2022, closing 1 position and reducing 53 holdings. Its most notable exit was CyrusOne Inc Common Stock, an estimated $403K position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 42% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Oak Associates opened a new position in ZimVie worth $242K.

  • Oak Associates's largest Q1 2022 buy was ZimVie: 10,616 shares worth $242K.
  • Oak Associates added most to Pfizer in Q1 2022, an estimated $1.24M increase.
  • Oak Associates's biggest Q1 2022 reduction was KLA, cutting an estimated $11.3M.
  • Oak Associates fully exited CyrusOne Inc Common Stock in Q1 2022, selling an estimated $403K.
  • Oak Associates's ten largest holdings make up 46% of its $1.64B portfolio in Q1 2022.
  • Oak Associates opened 1 new position and closed 1 in Q1 2022.
  • Oak Associates's portfolio value fell 13% quarter-over-quarter to $1.64B.

Based on Oak Associates's 13F filing for Q1 2022, filed 12 May 2022.